Sandra Levy
ARTICLES BY THIS AUTHOR
- 1/30/2020
Coborn's centralizes prescription fulfillment via McKesson HVS
Coborn's and McKesson HVS partnered to develop and execute a central fill strategy that meets Coborn's current business needs. - 1/29/2020
HTL-STREFA's Prevent DropSafe Safety Pen Needles awarded McKesson's 2019 New Product of the Year
The Prevent DropSafe Safety Pen Needle, which utilizes a thin 31-gauge needle, is McKesson's 2019 product of the year. - 1/29/2020
NACDS underscores pharmacy's key role in preventive care
Community pharmacies have broad-reaching impacts across communities in the United States, NACDS told CMS. - 1/28/2020
CVS Caremark's RxZero offers PBM members no-cost diabetes medications
A new plan design from CVS Caremark eliminates member cost as a barrier to medication adherence, without raising costs for benefits plan sponsors or increasing premiums or deductibles. - 1/28/2020
2020 could be a blockbuster year for drug approvals
Sixty-four drugs have been filed with the FDA and have anticipated approval dates in 2020, according to OptumRx's Drug Pipeline Insights Report. - 1/28/2020
FDA approves Teva's Ajovy auto-injector device
Ajovy offers patients the flexibility of quarterly 675 mg or monthly 225 mg dosing options. - 1/27/2020
Hy-Vee to open more Dollar Fresh stores in Iowa
Hy-Vee is set to rebrand six acquired Shopko stores under its Dollar Fresh banner. - 1/27/2020
FDA approves new indication for Lundbeck’s Sabril
Lundbeck's Sabril 's new indication approval closes the age gap for patients. - 1/27/2020
Alembic gets FDA nod for two generics
Azithromycin tablets and bosentan tablets have a market value of about $2 million, and $68 million respectively, for the 12 months ended September 2019. - 1/27/2020
Par launches authorized generic Carafate
Sucralfate oral suspension had a market value of roughly $285 million for the 12 months ended Nov. 30, 2019, according to IQVIA.
